Private company

Metsera, Inc.

American pharmaceutical preparations company based in New York.

Last updated Oct 18, 2026.

Overview

  • IndustryPharmaceutical Preparations
  • HeadquartersDE
  • Incorporated inDE2
  • Business address3 World Trade Center, 175 Greenwich Street, New York, Ny 100072
  • Filer category, Emerging growth company2

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Operating income3-$224.8M in 2024+415% since 2023
-$300.0M-$200.0M-$100.0M02023: -$43.7M-$43.7M20232024: -$224.8M-$224.8M2024+415%
Net income3-$209.1M in 2024+343% since 2023
-$300.0M-$200.0M-$100.0M02023: -$47.2M-$47.2M20232024: -$209.1M-$209.1M2024+343%
Fiscal year2022202320242025
Research and development$15.6M3$107.5M3
Operating income-$43.7M3-$224.8M3
Income tax$03-$9.3M3
Net income-$47.2M3-$209.1M3
Earnings per share-$3.483-$14.493
Earnings per share (diluted)-$3.483-$14.493

Compare Metsera, Inc. with another company

Leadership

Who has led Metsera, Inc., and when. Pick a name to see everywhere that person has worked.

Chair

  1. Clive Meanwell2025–now

Chief financial officer

  1. Christopher Visioli2025–now
Board members and other officers (9)

Filings

108 filings to the SEC since October 2021: 1 annual reports, 3 quarterly reports, 16 major events, 48 insider forms, 10 large holders, 1 private raises, 29 other. The latest 20:

  1. Feb 17, 2026SCHEDULE 13G/A EDGAR
  2. Nov 24, 202515-12G EDGAR
  3. Nov 17, 20254 EDGAR
  4. Nov 17, 2025SCHEDULE 13G/A EDGAR
  5. Nov 14, 2025SCHEDULE 13G EDGAR
  6. Nov 14, 20254 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  7. Nov 14, 2025SCHEDULE 13D/A EDGAR
  8. Nov 13, 2025SCHEDULE 13G/A EDGAR
  9. Nov 13, 20254 EDGAR
  10. Nov 13, 20254 EDGAR
  11. Nov 13, 20254 EDGAR
  12. Nov 13, 20254 EDGAR
  13. Nov 13, 20254 EDGAR
  14. Nov 13, 20254 EDGAR
  15. Nov 13, 20254 EDGAR
  16. Nov 13, 20254 EDGAR
  17. Nov 13, 20254 EDGAR
  18. Nov 13, 20254 EDGAR
  19. Nov 13, 20254 EDGAR
  20. Nov 13, 20254 EDGAR

The 108 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last three years, summarized. The full record is on SEC EDGAR.

Insider trades and holders

Large holders

Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 10 such filings since October 2021:

  1. Feb 17, 2026SCHEDULE 13G/A
  2. Nov 17, 2025SCHEDULE 13G/A
  3. Nov 14, 2025SCHEDULE 13G
  4. Nov 14, 2025SCHEDULE 13D/A
  5. Nov 13, 2025SCHEDULE 13G/A
  6. Oct 31, 2025SCHEDULE 13G
  7. Jun 3, 2025SCHEDULE 13G
  8. May 12, 2025SCHEDULE 13G/A
  9. Feb 10, 2025SCHEDULE 13D
  10. Feb 5, 2025SCHEDULE 13G

From Forms 4 and Schedules 13D and 13G filed with the SEC.

Money raised

Private offerings the company reported to the SEC on Form D.

  1. Nov 12, 2024Raised $215 million in a private offering of equity Form D: 38 investors so far Form D

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15